■ Published papers
|
Original article
|
|
1.
|
Nakashima I, Ohashi T, Yokoyama K, Kaida K, Nakahara J, Kondo T, Yoshikura N, Shimizu Y, Nohara C, Sakurai K, Yokote H, Niino M, Yamamura T, Fujihara K, Isobe N, Ochi H, Mori M, Kawachi I, Shimizu F, Kanda M, Tani Y, Fukazawa T.：
A multicenter, retrospective study in patients with multiple sclerosis treated with natalizumab in a real-world setting in Japan: The REFIND study.
Multiple sclerosis and related disorders.
：1
, 2026.1
DOI:10.1016/j.msard.2026.107007.
|
|
2.
|
SHIMIZU Yuko, NAKASHIMA Ichiro, IKEGUCHI Riyoutaro, Nagatsuka Tadashi, Yamashita Katsuhisa, Fukuoka Yuta, Murata Tatsunori, Fujihara Kazuo：
Impact of Symptoms of Neuromyelitis Optica Spectrum Disorder and Patient‐Determined Oral Glucocorticoid–Related Adverse Events on Patients' Daily Living and Emotions: A Qualitative Analysis From Japan.
Clinical and Experimental Neuroimmunology;
X
：X-X
, 2025.9
DOI:10.1111/cen3.70026
|
|
3.
|
IKEGUCHI Riyoutarou†, SHIMIZU Yuuko*, KURODA Rie, TOUDOU Ken'ichi：
Satralizumab treatment in neuromyelitis optica spectrum disorder: effects on relapse, pain, and other medications used: a retrospective chart review.
Multiple Screlosis And Related Disorders
：106706
, 2025.8
DOI:DOI: 10.1016/j.msard.2025.106706
|
|
Review article
|
|
1.
|
清水優子†：
母性神経学とは.
脳神経内科
104
(2)
：157-163
, 2026.2
|
|
2.
|
Yuko Shimizu†, Ryotaro Ikeguchi, Kazuo Fujihara, Kenichi Todo：
Progress in the management of pregnancy in patients with neuromyelitis optica spectrum disorder.
Therapeutic Advances in Neurological Disorders
18
：1-15
, 2025.10
DOI:https://doi.org/10.1177/17562864251384504
|
|
3.
|
清水優子†：
視神経脊髄炎スペクトラム障害で用いられるサトラリズマブ.
脳神経内科
102
(6)
：633-637
, 2025.6
|
|
Case report
|
|
1.
|
ISHII Makoto, IKEGUCHI Riyoutarou*, ARAI Satoko, SHIMIZU Yuuko, TOUDOU Ken'ichi：
Hydrocephalus as an Initial Presentation of Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-Associated Disease: A Case Report and Review of Tumor-Mimicking Demyelination.
Cureus
17
(8)
：e89246
, 2025.8
DOI:DOI: 10.7759/cureus.89246
|
|
Other
|
|
1.
|
川村純一†, 清水優子, 松村剛毅, 田畑務：
医療安全に向けた会員病院の取り組み（１）.
患者安全推進ジャーナル
80
：49-53
, 2025.6
|
|
To the top
|
|
■ Academic conference presentation
|
1.
|
◎SHIMIZU Yuko：
Pregnancy Topics in NMOSD and MOGAD.
Update on NMOSD & MOGAD 2026,
東京,
2026/02
|
|
2.
|
◎Yuko Shimizu, Ichiro Nakashima, Ryotaro Ikeguchi, Tadashi Nagatsuka, Katsuhisa Yamashita, Yuta Fukuoka, Tatsunori Murata、 Kazuo Fujihara：
A Qualitative Study on the Impact of Symptoms and Adverse Events of Oral
Glucocorticoids on Daily Life in Patients with Neuromyelitis Optica Spectrum Disorder.
ISNI2025,
千葉,
2025/10
|
|
3.
|
◎ARAI Satoko, ISHII Makoto, KURODA Rie, IKEGUCHI Ryotaro, SHIMIZU Yuko, TODO Kenichi：
Myelin oligodendrocyte glycoprotein antibody-associaet disease presenting with hydrocephalus mimicking a germ cell tumor: A case report.
Sendai Conference 2025,
仙台,
2025/07
|
|
4.
|
◎清水優子：
妊娠・授乳時の頭痛の治療薬の使いかた up to date 母性内科学をご存じですか？.
第53回日本頭痛学会総会,
横浜,
2025/11
|
|
5.
|
鈴木万恭子◎、花房規男、平野一、伊藤憲、堀元ひろみ、山崎かおり、松村剛毅、清水優子、世川修、西村勝治：
病室透析における当院の安全対策の取り組み.
第20回医療の質・安全学会学術集会,
京都,
2025/11
|
|
6.
|
◎清水優子：
NMOSDのNew era-患者さんの望みを叶えるー.
第43回日本神経治療学会学術集会,
熊本,
2025/11
|
|
7.
|
◎清水優子：
多発性硬化症～病態理解と治療の最前線～.
第5回妊娠と薬情報研究会学術集会 教育講演,
東京 お茶の水,
2025/10
|
|
8.
|
◎清水優子：
妊娠・出産と免疫性神経疾患.
日本母性内科学会 プロバイダーコース,
WEB,
2025/07
|
|
9.
|
◎清水優子：
多発性硬化症治療の現在地ーライフイベントを踏まえたMS治療 Update.
第66回日本神経学会学術集会,
大阪,
2025/05
|
|
Display 5 items
|
|
Display all(9)
|
|
To the top
|
|
